Applied DNA Sciences Stock Price. Everything You Need To Know About The Applied DNA Sciences Stock!

Applied DNA Sciences, Inc. is a company based in Stony Brook, New York, that focuses on developing and marketing technologies to produce and detect deoxyribonucleic acid (DNA). With 61 full-time employees and an IPO date of 2001-08-24, the company is known for its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform.

The platform produces large quantities of DNA that can be used in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets. Additionally, the platform is used for supply chain security, anti-counterfeiting, and anti-theft technology purposes.

Applied DNA Sciences, Inc. has also developed PCR-based molecular in vitro diagnostics for COVID-19, providing a vital solution for the current global pandemic. Its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, offers a high-throughput turnkey solution for population-scale COVID-19 testing called safeCircle. This solution utilizes the Company’s COVID-19 Diagnostic Tests and is designed to identify infection within defined populations or communities through high-throughput testing methodologies.

As the world continues to battle the COVID-19 pandemic, investing in companies that offer innovative solutions such as Applied DNA Sciences, Inc. can provide valuable insights and potential opportunities for investors. However, it is important to conduct thorough research and consult with financial professionals before making any investment decisions.

Staying informed on the latest developments in the biotechnology industry, including advancements in PCR-based molecular diagnostics and COVID-19 testing solutions, can help investors make informed decisions about their investments. Keeping an eye on trends such as stocks share price today and premarket activity can also provide valuable insights into market movements and potential investment opportunities.